California Nanotechnologies Balance Sheet Health
Financial Health criteria checks 6/6
California Nanotechnologies has a total shareholder equity of $801.0K and total debt of $590.2K, which brings its debt-to-equity ratio to 73.7%. Its total assets and total liabilities are $5.5M and $4.7M respectively. California Nanotechnologies's EBIT is $1.5M making its interest coverage ratio 8.6. It has cash and short-term investments of $657.5K.
Key information
73.7%
Debt to equity ratio
US$590.23k
Debt
| Interest coverage ratio | 8.6x |
| Cash | US$657.50k |
| Equity | US$801.03k |
| Total liabilities | US$4.67m |
| Total assets | US$5.47m |
Recent financial health updates
Recent updates
California Nanotechnologies Corp. (CVE:CNO) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Jun 30
With EPS Growth And More, California Nanotechnologies (CVE:CNO) Makes An Interesting Case
May 14California Nanotechnologies Corp.'s (CVE:CNO) Shares Climb 32% But Its Business Is Yet to Catch Up
Apr 07Earnings Not Telling The Story For California Nanotechnologies Corp. (CVE:CNO) After Shares Rise 29%
Jan 25Should You Be Adding California Nanotechnologies (CVE:CNO) To Your Watchlist Today?
Jan 17Subdued Growth No Barrier To California Nanotechnologies Corp.'s (CVE:CNO) Price
Jun 30Financial Position Analysis
Short Term Liabilities: CNO's short term assets ($3.0M) exceed its short term liabilities ($2.9M).
Long Term Liabilities: CNO's short term assets ($3.0M) exceed its long term liabilities ($1.8M).
Debt to Equity History and Analysis
Debt Level: CNO has more cash than its total debt.
Reducing Debt: CNO had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: CNO's debt is well covered by operating cash flow (128.9%).
Interest Coverage: CNO's interest payments on its debt are well covered by EBIT (8.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 04:55 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/08/31 |
| Annual Earnings | 2024/02/29 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
California Nanotechnologies Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|